Clinical trial

Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study

NCT07640048

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2025-05-04

PhaseN/A

Study timeline

Study start (actual)2025-05-04Date precision: day

Registry last updated2026-06-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Intrahepatic Cholangiocarcinoma (Icc)unresolved

Interventions

AdebrelimabDRUG

GemcitabineDRUG · verified · RxNorm: gemcitabine

CisplatinDRUG · verified · RxNorm: cisplatin

S-1DRUG

ApatinibDRUG

Sponsors & collaborators

Peking Union Medical College Hospitallead sponsor

Mapped research locations

BeijingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07640048 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.